Cargando…
Review of the Case Reports on Metformin, Sulfonylurea, and Thiazolidinedione Therapies in Type 2 Diabetes Mellitus Patients
Type 2 diabetes mellitus (T2DM) is the world’s most common metabolic disease. The development of T2DM is mainly caused by a combination of two factors: the failure of insulin secretion by the pancreatic β-cells and the inability of insulin-sensitive tissues to respond to insulin (insulin resistance)...
Autores principales: | Susilawati, Elis, Levita, Jutti, Susilawati, Yasmiwar, Sumiwi, Sri Adi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443323/ https://www.ncbi.nlm.nih.gov/pubmed/37606429 http://dx.doi.org/10.3390/medsci11030050 |
Ejemplares similares
-
Pharmacology activity, toxicity, and clinical trials of Erythrina genus plants (Fabaceae): an evidence-based review
por: Susilawati, Elis, et al.
Publicado: (2023) -
Role of the AMPK/SIRT1 pathway in non-alcoholic fatty liver disease (Review)
por: Anggreini, Putri, et al.
Publicado: (2022) -
Chitin Extracted from the Shell of Blue Swimming Crabs (Portunus pelagicus Linn.) Inhibits NF-kappaB p65 in Ethanol-Induced Gastric Ulcerative Wistar Rats
por: Amelia, Renny, et al.
Publicado: (2023) -
DPP4i, thiazolidinediones, or insulin and risks of cancer in patients with type 2 diabetes mellitus on metformin–sulfonylurea dual therapy with inadequate control
por: Wong, Carlos K H, et al.
Publicado: (2020) -
Phytosome drug delivery system for natural cosmeceutical compounds: Whitening agent and skin antioxidant agent
por: Susilawati, Yasmiwar, et al.
Publicado: (2021)